NCT07103200 Evaluation of Decision-Making Fatigue After Traumatic Brain Injury
| NCT ID | NCT07103200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | TBI (Traumatic Brain Injury) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2029-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-07-01 with a primary completion date of 2029-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a preliminary, prospective, cohort study to investigate the feasibility of using the COGED and Restless Bandit tasks after a mild to moderate traumatic brain injury as well as in healthy controls.
Eligibility Criteria
Inclusion Criteria for TBI Participants: * Adults 18 years and older * Diagnosis of a mild to moderate TBI (GCS \> 8 on admission) * Able to perform a computerized assessment * Willing to attend all scheduled appointments * Able to undergo the informed consent process Inclusion Criteria for Healthy Participants: * Adults 18 years and older * Able to perform a computerized assessment * Willing to attend all scheduled appointments * Able to undergo the informed consent process
Contact & Investigator
David Darrow, MD, MPH
PRINCIPAL INVESTIGATOR
Hennepin Healthcare Research Institute
Frequently Asked Questions
Who can join the NCT07103200 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying TBI (Traumatic Brain Injury). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07103200 currently recruiting?
Yes, NCT07103200 is actively recruiting participants. Contact the research team at rnl@umn.edu for enrollment information.
Where is the NCT07103200 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07103200 clinical trial?
NCT07103200 is sponsored by University of Minnesota. The principal investigator is David Darrow, MD, MPH at Hennepin Healthcare Research Institute. The trial plans to enroll 40 participants.